Vasculitis Foundation Announces Virtual Community Forum: Patient Perspectives
Image File
Original HTML

Spotlight Urgent Patient Needs and Treatment Gaps

KANSAS CITY, Mo., Oct. 30, 2026 /PRNewswire/ -- The Vasculitis Foundation (VF) is proud to announce the upcoming Vasculitis Community Forum: Patient Perspectives, a national virtual listening session taking place on Friday, November 20, 2026, from 12:00 PM to 2:00 PM ET. This landmark event will bring together patients, caregivers, clinicians, and key stakeholders from across the country to share lived experiences and highlight the urgent unmet needs in vasculitis careâespecially the need for safer, more effective alternatives to steroids.

A Critical Moment for the Vasculitis Community

Vasculitis encompasses nearly 20 rare diseases characterized by inflammation of the blood vessels, leading to significant health challenges and, in some cases, life-threatening complications. While there are approximately ten FDA-approved therapies, corticosteroids remain a mainstay of treatment for most patientsâdespite their substantial burden of side effects and long-term toxicity.

The Vasculitis Community Forum is being convened at a pivotal time, as the community awaits key regulatory decisions that could impact access to alternative therapies. A key objective is to ensure that all stakeholders, including regulators at the FDA, hear directly from patients about the urgent need for treatment options and the real-world impact of current therapies.

Forum Agenda and Highlights

The two-hour virtual event will feature:

- A brief overview of vasculitis and the current treatment landscape by clinical experts

- Two moderated patient and caregiver panels sharing real-world experiences and the daily impact of the disease

- A focused discussion on unmet needs and the critical importance of developing and maintaining access to alternative therapies

- Opportunities for participants to contribute via chat and real-time polling

Members of Congress, the FDA, and other regulatory officials are invited to attend in a listen-only capacity, ensuring that patient voices are heard at the highest levels. The Forum will be facilitated by Wendy K.D. Selig, Founder & CEO of WSCollaborative, who brings over 30 years of experience in health sector strategy and patient engagement.

Driving Change Through Patient Perspectives

"The timing is right for the Vasculitis Foundation to shine a spotlight on the unmet needs and treatment-related priorities of patients and their care teams," said Joyce Kullman, President of the Vasculitis Foundation. "By convening this Forum, we aim to provide a more complete picture of what it's like to live with and manage vasculitis todayâand to drive meaningful change in how therapies are developed, evaluated, and accessed."

Following the event, the VF will publish a comprehensive whitepaper summarizing key insights and recommendations, which will be widely disseminated to clinicians, therapy developers, media outlets, and regulators.

Join Us

Registration for the Vasculitis Community Forum is now open. Patients, caregivers, clinicians, and all interested stakeholders are encouraged to participate in this important conversation. For more information and to register, please click here.

About the Vasculitis Foundation

The Vasculitis Foundation is the leading organization in the United States dedicated to improving the lives of people living with vasculitis through research, education, support, and advocacy.

Media Contact:

Joyce A. Kullman

President

Vasculitis Foundation

[email protected]

SOURCE VASCULITIS FOUNDATION

Share this article

Class (B2B/B2C)
B2C
Ingest Status
Need Review
Dedupe hash
prn_302925322
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): Target introduces an unsupported claim that the event is 'free-to-join-style'; the source only says registration is open and does not state whether there is a fee.
Source Name
Vasculitis Foundation Announces Virtual Community Forum
Original Summary

<p>Spotlight Urgent Patient Needs and Treatment Gaps KANSAS CITY, Mo., Oct. 30, 2026 /PRNewswire/ -- The Vasculitis Foundation (VF) is proud to announce the upcoming Vasculitis Community Forum: Patient Perspectives, a national virtual listening session taking place on Friday, November 20,...</p>

Original Link
Original Source
Image URL
https://mmx.prnewswire.com/media/MS2024647/Vasculitis_Foundation_Logo_RGB-Web-2026.jpg?id=OA3050272&p=facebook
Generated Article_json
{"target_audience": "b2c", "is_medical": true, "ai_generated_title": "Vasculitis Patients Get a National Stage on Nov. 20", "body_html": "<p><strong>Kansas City -- [CURRENT_DATE] --</strong> The Vasculitis Foundation will host a free-to-join-style virtual listening session, the Vasculitis Community Forum: Patient Perspectives, on Friday, November 20, 2026, from 12:00 PM to 2:00 PM ET, and registration is now open.</p><p>The event brings together patients, caregivers, clinicians and other stakeholders to describe life with the disease. Their main focus is the need for safer, more effective alternatives to steroids.</p><h5>Steroids remain the mainstay despite heavy side effects</h5><p>Vasculitis covers nearly 20 rare diseases marked by inflammation of the blood vessels, and some cases bring life-threatening complications. Roughly ten therapies are FDA-approved, yet corticosteroids are still a core treatment for most patients, even with their side effects and long-term toxicity.</p><p>The foundation says the community is awaiting key regulatory decisions that could affect access to alternative therapies.</p><h5>Two patient panels and live polling fill the two-hour agenda</h5><p>The program opens with a short overview of vasculitis and current treatment by clinical experts. Two moderated panels of patients and caregivers follow, describing the daily impact of the disease. A discussion of unmet needs and access to alternative therapies comes next. Attendees can join in through chat and real-time polling.</p><p>Members of Congress, the FDA and other regulatory officials are invited to attend in a listen-only capacity. Wendy K.D. Selig, Founder and CEO of WSCollaborative, will facilitate. She has over 30 years of experience in health sector strategy and patient engagement.</p><h5>A whitepaper will carry patient insights to regulators</h5><p>Foundation President Joyce Kullman said the goal is to give \"a more complete picture\" of living with and managing vasculitis today.</p><p>After the event, the foundation will publish a whitepaper of key insights and recommendations. It will go to clinicians, therapy developers, media outlets and regulators.</p>", "meta_description": "The Vasculitis Foundation hosts a virtual forum on Nov. 20, 2026, 12-2 PM ET, spotlighting patient needs and the push for safer alternatives to steroids.", "seo_keywords": "vasculitis, Vasculitis Foundation, patient forum, corticosteroids, steroid alternatives, rare disease, FDA, virtual event, caregivers", "companies": ["Vasculitis Foundation", "WSCollaborative"], "topics": ["Health, Wellness & Beauty", "Public Health"], "markets": ["United States"], "locations": ["Kansas City"], "products": [], "cta_text": "Register for the Vasculitis Community Forum on the Vasculitis Foundation's event page", "learn_more": "", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}
Content Hash (SHA-256, erste 32 hex)
1fb90a6403445a0988e685f3d821c09d